Read More 3 minute read Pharma Industry News Foresee Pharmaceuticals gains third DSMB endorsement for Casppian Phase 3 study, strengthening confidence in long-acting Leuprolide formulation The latest safety review supports Foresee Pharmaceuticals’ continued progress in developing a long-acting leuprolide injectable emulsion for pediatric… byPallavi MadhirajuFebruary 17, 2025